On Friday, Voyager Therapeutics Inc (NASDAQ: VYGR) opened at On Friday, higher 7.27% from the last session, before settling in for the closing price of $3.30. Price fluctuations for VYGR have ranged from $2.64 to $9.55 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -5.18% over the past five years. Company’s average yearly earnings per share was noted -75.31% at the time writing. With a float of $45.00 million, this company’s outstanding shares have now reached $55.21 million.
Let’s look at the performance matrix of the company that is accounted for 172 employees. In terms of profitability, gross margin is 48.55%, operating margin of -152.03%, and the pretax margin is -125.46%.
Voyager Therapeutics Inc (VYGR) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Voyager Therapeutics Inc is 18.69%, while institutional ownership is 62.86%. The most recent insider transaction that took place on Apr 02 ’25, was worth 34,595. In this transaction Chief Medical Officer of this company sold 10,086 shares at a rate of $3.43, taking the stock ownership to the 157,914 shares. Before that another transaction happened on Apr 02 ’25, when Company’s President and CEO sold 10,885 for $3.43, making the entire transaction worth $37,336. This insider now owns 430,931 shares in total.
Voyager Therapeutics Inc (VYGR) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -75.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.46% during the next five years compared to 1.48% growth over the previous five years of trading.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
Check out the current performance indicators for Voyager Therapeutics Inc (VYGR). In the past quarter, the stock posted a quick ratio of 6.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -1.67 in one year’s time.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Voyager Therapeutics Inc (NASDAQ: VYGR) saw its 5-day average volume 1.65 million, a positive change from its year-to-date volume of 0.42 million. As of the previous 9 days, the stock’s Stochastic %D was 68.36%. Additionally, its Average True Range was 0.25.
During the past 100 days, Voyager Therapeutics Inc’s (VYGR) raw stochastic average was set at 27.00%, which indicates a significant decrease from 82.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.68% in the past 14 days, which was higher than the 71.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.27, while its 200-day Moving Average is $5.14. Nevertheless, the first resistance level for the watch stands at $3.68 in the near term. At $3.82, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.01. If the price goes on to break the first support level at $3.35, it is likely to go to the next support level at $3.17. The third support level lies at $3.03 if the price breaches the second support level.
Voyager Therapeutics Inc (NASDAQ: VYGR) Key Stats
There are currently 55,336K shares outstanding in the company with a market cap of 195.89 million. Presently, the company’s annual sales total 80,000 K according to its annual income of -65,000 K. Last quarter, the company’s sales amounted to 6,470 K and its income totaled -31,020 K.
